Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Active not recruiting 2Completed 1

Sponsor Class

OTHER 3NIH 3NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Lymphoma 3Hodgkin Disease 3

Interventions

Doxorubicin 13Bleomycin 12Vinblastine 11Prednisone 11Vincristine 10Etoposide 10Cyclophosphamide 10Radiotherapy 9Filgrastim 9Dacarbazine 7Procarbazine 6Granulocyte Colony-Stimulating Factor 5Dexamethasone 5ABVD protocol 5Vinorelbine 4Peripheral Blood Stem Cell Transplantation 4Melphalan 4Gemcitabine 4Cytarabine 4Cisplatin 4Carmustine 4etoposide phosphate 3Mechlorethamine 3Ifosfamide 3indolepropanol phosphate 2Whole-Body Irradiation 2Positron Emission Tomography Computed Tomography 2Polymerase Chain Reaction 2Podophyllotoxin 2Nivolumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Hodgkin Disease × Mechlorethamine × Clear all
NCT00002462 2025-08-05

RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Active not recruiting
615 enrolled
Lymphoid

Hodgkin Disease, Lymphoma

NCT00379041 2025-08-05

Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Active not recruiting
1,158 enrolled
Lymphoid

Hodgkin Disease, Lymphoma

NCT00003389 2023-06-29

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma

Eastern Cooperative Oncology Group

Phase 3 Completed
854 enrolled 9 charts
Lymphoid

Hodgkin Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡